Date-stamp loading
Version status: In force | Document consolidation status: Updated to reflect all known changes
Version date: 28 February 2020 - onwards
  Version 7 of 7    

Schedule 1, Part 1 Interpretation (paras. 1-2)

Regulation 49

Interpretation of Schedule 1

1. In this Schedule -

"the EMIR regulation" means Regulation (EU) 648/2012 of the European Parliament and of the Council of 4 July 2012 on OTC derivatives, central counterparties and trade repositories [OJ No L173, 12/6/2014, p84.] as last amended by Regulation (EU) 2019/2099 of the European Parliament and of the Council of 23 October 2019;

"management body" in relation to a person (ā€œPā€) means - (a) the board of directors, or if there is no such board, the equivalent body responsible for the management of P; and(b) any other person who effectively directs the business of P;

"non-authorised counterparty" means - (a) a financial counterparty (within the meaning of Article 2.8 of the EMIR regulation) who is neither an authorised person nor a recognised body; or (b) a non-financial counterparty (within the meaning of Article 2.9 of the EMIR regulation) who meets the conditions in Article 10.1.b of that regulation;

"PRA-authorised person"

Comparing proposed amendment...